International Conference in Malignant Lymphoma (ICML) 2019 – STRO-001 Poster

Preliminary results of a Phase 1 dose escalation study of the first-in-class anti-CD74 antibody drug conjugate (ADC), STRO-001, in patients with advanced B-cell malignancies. Please Click the Link, International Conference in Malignant Lymphoma 2019 poster to enlarge.

The release as fetched from its publisher. sutrobio.com ↗